Activation of Thrombin-activable Fibrinolysis Inhibitor Requires Epidermal Growth Factor-like Domain 3 of Thrombomodulin and Is Inhibited Competitively by Protein C

This publication has 25 references indexed in Scilit:

• Thrombin, Thrombomodulin and TAFI in the Molecular Link Between Coagulation and Fibrinolysis
  Thrombosis and Haemostasis, 1997
• TAFI, or Plasma Procarboxypeptidase B, Couples the Coagulation and Fibrinolytic Cascades through the Thrombin-Thrombomodulin Complex
  Published by Elsevier ,1996
• How to measure and predict the molar absorption coefficient of a protein
  Protein Science, 1995
• Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface
  The FASEB Journal, 1995
• Purification and Characterization of TAFI, a Thrombin-activable Fibrinolysis Inhibitor
  Journal of Biological Chemistry, 1995
• Structure-function studies of the epidermal growth factor domains of human thrombomodulin
  Biochemical and Biophysical Research Communications, 1992
• Purification and characterization of a new arginine carboxypeptidase in human serum
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1990
• The amino‐terminal domain of thrombomodulin and pancreatic stone protein are homologous with lectins
  FEBS Letters, 1988
• Human thrombomodulin: complete cDNA sequence and chromosome localization of the gene
  Biochemistry, 1987
• Characterization of a thrombomodulin cDNA reveals structural similarity to the low density lipoprotein receptor.
  Proceedings of the National Academy of Sciences, 1986